Biomedical Engineering Reference
In-Depth Information
106. Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CM. Pulmonary bioassay studies with nanoscale and
fine-quartz particles in rats: Toxicity is not dependent upon particle size but on surface characteristics.
Toxicological Sciences
. 2007;95(1):270-80.
107. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of tox-
icity tests using ultrafine TiO
2
particles as a component of nanoparticle risk management.
Toxicology
Letters
. 2007;171(3):99-110.
108. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: New insights into their cel-
lular reduction.
Biotechnology Annual Review
. 2005;11:127-52.
109. Hussain S, Hess K, Gearhart J, Geiss K, Schlager J.
In vitro
toxicity of nanoparticles in BRL 3A rat liver
cells.
Toxicology in Vitro
. 2005;19(7):975-83.
110. Plumb JA, Milroy R, Kaye S. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel
tetrazolium-based assay.
Cancer Research
. 1989;49(16):4435-40.
111. Wörle-Knirsch J, Pulskamp K, Krug H. Oops they did it again! Carbon nanotubes hoax scientists in
viability assays.
Nano Letters
. 2006;6(6):1261-8.
112. Davis R, Lockwood P, Hobbs D, Messer R, Price R, Lewis J et al.
In vitro
biological effects of
sodium titanate materials.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
.
2007;83(2):505-11.
113. Yamin T-T, Ayala JM, Miller DK. Activation of the native 45-kDa precursor form of interleukin-1-
converting enzyme.
Journal of Biological Chemistry
. 1996;271(22):13273-82.
114. Srinivasula SM, Saleh A, Ahmad M, Fernandes-Alnemri T, Alnemri ES. Isolation and assay of caspases.
Methods in Cell Biology
. 2001;66:1-27.
115. Wróblewski F, Ladue JS, eds. Lactic dehydrogenase activity in blood.
Proceedings of the Society for
Experimental Biology and Medicine Society for Experimental Biology and Medicine
(New York, NY);
1955: Royal Society of Medicine.
116. Choi SY, Jeong S, Jang SH, Park J, Park JH, Ock KS et al.
In vitro
toxicity of serum protein-
adsorbed citrate-reduced gold nanoparticles in human lung adenocarcinoma cells.
Toxicology in Vitro
.
2012;26(2):229-37.
117. Babson AL, Phillips G. A rapid colorimetric assay for serum lactic dehyurogenase.
Clinica Chimica
Acta
. 1965;12(2):210-5.
118. Suska F, Gretzer C, Esposito M, Tengvall P, Thomsen P. Monocyte viability on titanium and copper
coated titanium.
Biomaterials
. 2005;26(30):5942-50.
119. Strauss GH. Non-random cell killing in cryopreservation: Implications for performance of the battery of
leukocyte tests (BLT), I. Toxic and immunotoxic effects.
Mutation Research/Environmental Mutagenesis
and Related Subjects
. 1991;252(1):1-15.
120. Park MV, Annema W, Salvati A, Lesniak A, Elsaesser A, Barnes C et al.
In vitro
developmental toxic-
ity test detects inhibition of stem cell differentiation by silica nanoparticles.
Toxicology and Applied
Pharmacology
. 2009;240(1):108-16.
121. Passagne I, Morille M, Rousset M, Pujalté I, L'Azou B. Implication of oxidative stress in size-dependent
toxicity of silica nanoparticles in kidney cells.
Toxicology
. 2012;299(2):112-24.
122. Herzog E, Casey A, Lyng FM, Chambers G, Byrne HJ, Davoren M. A new approach to the toxicity test-
ing of carbon-based nanomaterials—The clonogenic assay.
Toxicology Letters
. 2007;174(1):49-60.
123. Ye Y, Liu J, Chen M, Sun L, Lan M.
In vitro
toxicity of silica nanoparticles in myocardial cells.
Environmental Toxicology and Pharmacology
. 2010;29(2):131-7.
124. Lee JK, Kim DB, Kim JI, Kim PY.
In vitro
cytotoxicity tests on cultured human skin fibroblasts to predict
skin irritation potential of surfactants.
Toxicology in Vitro
. 2000;14(4):345-9.
125. Nemes Z, Dietz R, Lüth J, Gomba S, Hackenthal E, Gross F. The pharmacological relevance of vital
staining with neutral red.
Experientia
. 1979;35(11):1475-6.
126. Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C et al. The ECVAM international val-
idation study on
in vitro
tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm
assays and on the skin integrity function test.
ATLA—Alternatives to Laboratory Animals
. 2007;35(6):559.
127. Ramires P, Romito A, Cosentino F, Milella E. The influence of titania/hydroxyapatite composite coatings
on
in vitro
osteoblasts behaviour.
Biomaterials
. 2001;22(12):1467-74.
128. Monteiro-Riviere NA, Inman AO, Zhang L. Limitations and relative utility of screening assays to
assess engineered nanoparticle toxicity in a human cell line.
Toxicology and Applied Pharmacology
.
2009;234(2):222-35.
129. Huang M, Khor E, Lim L-Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of
molecular weight and degree of deacetylation.
Pharmaceutical Research
. 2004;21(2):344-53.
